Credit: Shutterstock photoAmerican depository receipts of European stocks were 0.2% lower at 135.08 on the Bank of New York Mellon Europe ADR Index on Tuesday morning.
Decliners in Continental Europe were led by Cellectis ( CLLS ), a French genome engineering company, 23.7% lower, followed by CGG ( CGG ), a manufacturer of geophysical equipment, down by 11.1% and Materialise ( MTLS ), a Belgian provider of 3D printing software and services, down by 3.3%. Telecom Italia ( TI ), an Italian telecommunications company, was 2.6% lower.
In the UK, Motif Bio ( MTFB ), a clinical-stage biopharmaceutical company, was 4.7% lower, followed by Verona Pharma (VRNA), a clinical-stage biopharmaceutical company, down by 2.0% and Carnival (CUK), a cruise vacation company, 1.9% lower. Avadel (AVDL), a specialty pharmaceutical company, was 1.9% lower.
Gainers in Continental Europe were led by Advanced Accelerator Applications (AAAP), a radiopharmaceutical company, 4.8% higher, followed by Forward Pharma (FWP), a Danish biopharmaceutical company, up by 2.1% and Koninklijke Philips Electronics - New York Shares (PHG), a Dutch diversified technology company, 2% higher. ABB (ABB), a technology company, was up by 1.9%.
And, in the UK, Amec Foster Wheeler (AMFW), a global engineering conglomerate, was 7.3% higher, Akari Therapeutics (AKTX), a development-stage biopharmaceutical company, was up by 4.4%, Randgold Resources (GOLD), a gold-mining company, was up by 2.1% and AstraZeneca, a biopharmaceutical company, was 1.0% higher.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
